Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, par value $0.0001 per share · CUSIP: 76152G100

Event date: 2025-06-27

Filing-level shares
3,612,384.00
Percent of class
5.2%
  • Bhat LaxminarayanReported CIK 0001818245

    Shares: 3,612,384.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-25-021746
Form type
SCHEDULE 13D/A
Filer
Bhat Laxminarayan
CIK
CIK 1818245
Filed
Jul 01, 2025
Reporting period
Jun 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub